Summary
A single oral dose of indomethacin 1 mg/kg was given to 6 male and 6 female volunteers. The formation of thromboxane B2 (TXB2) and 6-ketoprostaglandin F1α (6-keto-PGF1α) in clotting whole blood was measured by radioimmunoassay, and platelet aggregation induced by archidonic acid (AA) was measured with a plasma aggregometer. The results were related to the concomitant plasma concentration of indomethacin. The maximum plasma concentration ranged between 3.24 and 8.11 µg/ml and the elimination half-life between 4 and 11 h. Formation of the prostanoids was reversibly inhibited, with maximum suppression when the drug concentration in plasma exceeded 0.5–1.0 µg/ml; the IC50 was approximately 0.1 µg/ml. Platelet aggregation was also reversibly inhibited. The correlation between the formation of prostanoids and the different phases of the aggregatory response to exogenous AA is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature N Biol 231: 232–235
Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature N Biol 231: 235–237
Gryglewski RJ (1977) Prostaglandin and thromboxane biosynthesis inhibitors. Naunyn-Schmiedebergs Arch Pharmacol 297: S85-S88
Rane A, Oelz O, Frolich JC, Seyberth HW, Sweetman BJ, Watson JT, Wilkinson GR, Oates JA (1978) Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther 23: 658–668
Vargaftig BB, Zirinis P (1973) Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nature N Biol 244: 114–116
Fratantoni JC, Poindexter BJ (1981) Characterization of the platelet response to exogenous arachidonic acid. Thromb Res 22: 157–166
Maguire, ED, Pay GF, Wallis RB, White AM (1981) Prolonged inhibition of ex vivo sodium arachidonate-induced platelet aggregation and malondialdehyde (MDA) production by sulphinpyrazone (Anturan) in man. Thromb Res 21: 321–327
FitzGerald GA, Brash AR, Oates JA, Pedersen AK (1983) Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest 71: 1336–1343
Patscheke H, Stegmeier K (1984) Investigations on a selective nonprostanoic thromboxane antagonist, BM 13–177, in human platelets. Thromb Res 33: 277–288
Vinge E, Corell T, Andersson K-E (1984) Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin F1α. Eur J Clin Pharmacol 26: 711–717
Patrono C, Ciabattoni G, Pinca E, Pugliese F, Gastrucci G, De Salvo A, Satta MA, Peskar BA (1980) Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 17: 317–327
Jensen KM (1978) Determination of indomethacin in serum by an extractive alkylation technique and gas-liquid chromatography. J Chromatogr 153: 195–202
Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18: 364–373
Cockbill SR, Heptinstall S, Taylor PM (1979) A comparison of the abilities of acetylsalicylic acid, flurbiprofen and indomethacin to inhibit the release reaction and prostaglandin synthesis in human blood platelets. Br J Pharmacol 67: 73–78
Leach CM, Thorburn GD (1980) A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins 20: 51–56
Parry MJ, Randall MJ, Tyler HM, Myhre E, Dale J, Thaulow E (1982) Selective inhibition of thromboxane synthetase by dazoxiben increases prostacyclin production by leucocytes in angina patients and healthy volunteers. Lancet 2: 164
Pedersen AK, Watson ML, FitzGerald GA (1984) Inhibition thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1α. Thromb Res 33: 99–103
Pitzke B, Rücker W, Schrör K (1984) Formation of PGI2, PGE2 and TxB2 in whole blood in vitro and its pharmacological modification. Abstract presented at the British Pharmacological Society Meeting 1983, Galway, Ireland, Br J Pharmacol 80: 700 P
Orchard MA, Blair IA, Dollery CT, Lewis PJ (1983) Blood can synthesize prostacyclin. Lancet 2: 565
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vinge, E. Arachidonic acid — Induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin. Eur J Clin Pharmacol 28, 163–169 (1985). https://doi.org/10.1007/BF00609686
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609686